S. Saito et al., Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells, J HEART LUN, 18(10), 1999, pp. 937-945
Background: We find that chronic estradiol treatment inhibits the developme
nt of transplant arteriosclerosis (TA). The mechanism of this inhibition re
mains unclear. The objective of this study is to investigate in a non-cyclo
sporin-requiring TA model whether estradiol-17 beta treatment modulates the
expression of both endothelial nitric oxide synthase (ecNOS) and inducible
nitric oxide synthase (iNOS) in the early phase following transplantation
Methods: Orthotopic abdominal aorta allograft transplantation was performed
in male rats using Brown-Norway rats as donors and Lewis rats as recipient
s. The recipients (n = 50) were treated with estradiol 20 mu g/kg/day or pl
acebo by osmotic minipump from 2 days prior to surgery until sacrifice on p
ost-operative days 1, 3, 7, 14, and 21. The allografts were harvested and c
ross-sections of the vascular tissues were used for immunohistochemical sta
ining of ecNOS and iNOS. The effects of estradiol on cytokine-induced (tumo
r necrosis factor-alpha and interleukin-l beta) iNOS protein and messenger
RNA (mRNA) expression were also evaluated on rat aorta smooth muscle cells
by Western blotting and RT-PCR in vitro, respectively.
Results: The expression of ecNOS and iNOS was graded semiquantitatively fro
m 0 to +3. Estrogen elevates ecNOS expression in the intima in the early ph
ase following transplantation, 0.85 +/- 0.14 (day 7) and 1.08 +/- 0.11 (day
14) vs 1.53 +/- 0.25 (day 7) and 1.60 +/- 0.17 (day 14) for placebo and es
tradiol treated groups respectively, p < 0.01. Estrogen suppresses iNOS exp
ression in neointima (0.67 +/- 0.17 vs 0.24 +/- 0.04, p < 0.01, day 14), me
dia (1.03 +/- 0.15 vs 0.4 +/- 0.09, p < 0.01, day 7), and adventitia (1.55
+/- 0.12 vs 1.02 +/- 0.10, p < 0.05, day 14) in the same phase. Estradiol t
reatment inhibits cytokine-induced iNOS mRNA expression in cultured smooth
muscle cells.
Conclusions: Chronic estrogen treatment modulates both ecNOS and iNOS expre
ssion in the early phase following transplantation. This is associated with
the estrogen-protective effects on TA.